StockNews.AI
HAE
StockNews.AI
12 days

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

1. Haemonetics announces FY26 first quarter financial results available online. 2. Conference call scheduled for August 7, 2025, to discuss results. 3. Company focuses on improving medical care and plasma collection technologies. 4. Webcast replay available for one year after the call. 5. Investors encouraged to participate and access earnings release online.

Earnings
-28.68%Current Return
VS
+0.61%S&P 500
$75.7708/07 06:10 AM EDTEvent Start
$54.0408/08 12:57 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Neutral?

The announcement of earnings results typically does not indicate market movement until detailed insights are provided. Previous financial releases have had varied impacts based on results.

How important is it?

The upcoming earnings call may provide critical insights into company performance, affecting near-term stock perceptions.

Why Short Term?

Market reaction will depend on financial results communicated in the upcoming call, likely influencing stock price in the following days.

Related Companies

ABTMDT
Financial release accessible online, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website.The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information: Teleconference link:https://register-conf.media-server.com/register/BIb1de2bd7b8ba4267b7bc38da4e4008c7 Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/wv7zkgdh In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.Direct link to 1Q FY26 Earnings Release:https://haemonetics.gcs-web.com/static-files/078498e0-b75c-4cd4-94fb-93730b3b1c70A replay of the conference call and webcast will be available for one year beginning on August 7, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.ABOUT HAEMONETICSHaemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com. Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury  David Trenk, Manager-Investor Relations (781) 356-9763 (203) 733-4987 [email protected] [email protected] Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 [email protected] SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News